1,446
Views
0
CrossRef citations to date
0
Altmetric
Research Paper

Long non-coding RNA p53 upregulated regulator of p53 levels (PURPL) promotes the development of gastric cancer

, , , , &
Pages 1359-1376 | Received 23 Aug 2021, Accepted 07 Dec 2021, Published online: 11 Jan 2022

References

  • Jemal A, Center MM, DeSantis C, et al. Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biomarkers Prev. 2010Aug;19(8):1893–1907. Epub 2010 Jul 20. PMID: 20647400.
  • Smyth EC, Nilsson M, Grabsch HI, et al. Gastric cancer. Lancet. 2020Aug29;396(10251):635–648. PMID: 32861308.
  • Karimi P, Islami F, Anandasabapathy S, et al. Gastric cancer: descriptive epidemiology, risk factors, screening, and prevention. Cancer Epidemiol Biomarkers Prev. 2014May;23(5):700–713. Epub 2014 Mar 11. PMID: 24618998; PMCID: PMC4019373.
  • Cunningham SC, Kamangar F, Kim MP, et al. Survival after gastric adenocarcinoma resection: eighteen-year experience at a single institution. J Gastrointest Surg. 2005May-Jun;9(5):718–725. PMID: 15862270.
  • Digklia A. Advanced gastric cancer: current treatment landscape and future perspectives. World J Gastroenterol. 2016Feb28;22(8):2403–2414. i8.2403. PMID: 26937129; PMCID: PMC4768187.
  • Song Z, Wu Y, Yang J, et al. Progress in the treatment of advanced gastric cancer. Tumour Biol. 2017Jul;39(7):1010428317714626. PMID: 28671042.
  • Jathar S, Kumar V, Srivastava J, et al. Technological Developments in lncRNA Biology. Adv Exp Med Biol. 2017;1008:283–323. PMID: 28815544.
  • Liu K, Zhao D, Wang D. LINC00528 regulates myocardial infarction by targeting the miR-143-3p/COX-2 axis. Bioengineered. 2020Dec;11(1):11–18. PMID: 31833800; PMCID: PMC6961595.
  • Ding J, Cao J, Chen Z, et al. The role of long intergenic noncoding RNA 00511 in malignant tumors: a meta-analysis, database validation and review. Bioengineered. 2020 Dec;11(1):812–823.
  • Thin KZ, Liu X, Feng X, et al. LncRNA-DANCR: a valuable cancer-related long non-coding RNA for human cancers. Pathol Res Pract. 2018Jun;214(6):801–805. Epub 2018 Apr 24. PMID: 29728310.
  • Deng W, Zhang Y, Cai J, et al. LncRNA-ANRIL promotes gastric cancer progression by enhancing NF-kB signaling. Exp Biol Med (Maywood). 2019Sep;244(12):953–959. Epub 2019 Jun 26. PMID: 31242038; PMCID: PMC6879767.
  • Li H, Wang Y. Long Noncoding RNA (lncRNA) MIR22HG Suppresses Gastric Cancer Progression through Attenuating NOTCH2 Signaling. Med Sci Monit. 2019Jan23;25:656–665. PMID: 30670679; PMCID: PMC6352764.
  • Fu X, Wang Y, Wu G, et al. Long noncoding RNA PURPL promotes cell proliferation in liver cancer by regulating p53. Mol Med Rep. 2019Jun;19(6):4998–5006. Epub 2019 Apr 12. PMID: 31059022.
  • Zhang R, He T, Shi H, et al. Disregulations of PURPL and MiR-338-3p Could Serve As Prognosis Biomarkers for Epithelial Ovarian Cancer. J Cancer. 2021Jul25;12(18):5674–5680. PMID: 34405027; PMCID: PMC8364645.
  • Chen L, Heikkinen L, Wang C, et al. Trends in the development of miRNA bioinformatics tools. Brief Bioinform. 2019Sep27;20(5):1836–1852. PMID: 29982332; PMCID: PMC7414524.
  • Correia de Sousa M, Gjorgjieva M, Dolicka D, et al. Deciphering miRNAs’ Action through miRNA Editing. Int J Mol Sci. 2019Dec11;20(24):6249. PMID: 31835747; PMCID: PMC6941098.
  • Shin VY. MiRNA as potential biomarkers and therapeutic targets for gastric cancer. World J Gastroenterol. 2014Aug14;20(30):10432–10439. PMID: 25132759; PMCID: PMC4130850.
  • Mu L, Yang F, Guo D, et al. Overexpression of secretory clusterin (sCLU) induces chemotherapy resistance in human gastric cancer cells by targeting miR-195-5p. Bioengineered. 2020Dec;11(1):472–483. PMID: 32250192; PMCID: PMC7161562.
  • Pei Y, Tang Z, Cai M, et al. MicroRNA miR-425 promotes tumor progression by inhibiting Dickkopf-related protein-3 in gastric cancer. Bioengineered. 2021Dec;12(1):2045–2054. PMID: 34124998.
  • He X, Zou K. MiRNA-96-5p contributed to the proliferation of gastric cancer cells by targeting FOXO3. J Biochem. 2020Jan1;167(1):101–108. PMID: 31598681.
  • Wang C, Huang Y, Zhang J, et al. MiRNA-339-5p suppresses the malignant development of gastric cancer via targeting ALKBH1. Exp Mol Pathol. 2020Aug; 115: 104449. Epub 2020 May 5. PMID: 32380054.
  • Duan J, Lu G, Li Y, et al. Tao H. miR-137 functions as a tumor suppressor gene in pituitary adenoma by targeting AKT2. Int J Clin Exp Pathol. 2019 May 1;12(5):1557–1564. PMID: 31933973; PMCID: PMC6947140.
  • Ding X, Zhang J, Feng Z, et al. MiR-137-3p Inhibits Colorectal Cancer Cell Migration by Regulating a KDM1A-Dependent Epithelial-Mesenchymal Transition. Dig Dis Sci. 2020Aug4;66(7):2272–2282. Epub ahead of print. PMID: 32749639.
  • Zheng X, Wang X, Zheng L, et al. Construction and Analysis of the Tumor-Specific mRNA-miRNA-lncRNA Network in Gastric Cancer. Front Pharmacol. 2020Jul21;11:1112. PMID: 32848739; PMCID: PMC7396639.
  • Wang J, Ding Y, Wu Y, et al. Identification of the complex regulatory relationships related to gastric cancer from lncRNA-miRNA-mRNA network. J Cell Biochem. 2020Jan;121(1):876–887. Epub 2019 Aug 26. PMID: 31452262.
  • Chen Z, Wu J, Huang W, et al. Long Non-Coding RNA RP11-789C1.1 Suppresses Epithelial to Mesenchymal Transition in Gastric Cancer Through the RP11-789C1.1/MiR-5003/E-Cadherin Axis. Cell Physiol Biochem. 2018;47(6):2432–2444. Epub 2018 Jul 10. PMID: 29991048.
  • Gupta S, Singh AK, Prajapati KS, et al. Emerging role of ZBTB7A as an oncogenic driver and transcriptional repressor. Cancer Lett. 2020Jul28;483:22–34. Epub 2020 Apr 26. PMID: 32348807.
  • Wang S, Li P, Jiang G, et al. Long non-coding RNA LOC285194 inhibits proliferation and migration but promoted apoptosis in vascular smooth muscle cells via targeting miR-211/PUMA and TGF-β1/S100A4 signal. Bioengineered. 2020Dec;11(1):718–728. PMID: 32619136; PMCID: PMC8291892.
  • Fu Y, Hu X, Gao Y, et al. LncRNA ROR/miR-145-5p axis modulates the osteoblasts proliferation and apoptosis in osteoporosis. Bioengineered. 2021Dec;12(1):7714–7723. PMID: 34617877.
  • Xu M, Chen X, Lin K, et al. The long noncoding RNA SNHG1 regulates colorectal cancer cell growth through interactions with EZH2 and miR-154-5p. Mol Cancer. 2018Sep28;17(1):141. PMID: 30266084; PMCID: PMC6162892.
  • Wang X, Li T. Ropivacaine inhibits the proliferation and migration of colorectal cancer cells through ITGB1. Bioengineered. 2021Dec;12(1):44–53. PMID: 33345684.
  • Duan L, Tao J, Yang X, et al. HVEM/HIF-1α promoted proliferation and inhibited apoptosis of ovarian cancer cells under hypoxic microenvironment conditions. J Ovarian Res. 2020 Apr 20;13(1):40.
  • Li JH, Liu S, Zhou H, et al. starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data. Nucleic Acids Res. 2014Jan;42( Database issue):D92–7. Epub 2013 Dec 1. PMID: 24297251; PMCID: PMC3964941.
  • Hu YP, Jin YP, Wu XS, et al. LncRNA-HGBC stabilized by HuR promotes gallbladder cancer progression by regulating miR-502-3p/SET/AKT axis. Mol Cancer. 2019Nov21;18(1):167. Erratum in: Mol Cancer. 2021 Aug 28;20(1):110. PMID: 31752906; PMCID: PMC6868746.
  • Guan S, Jin T, Han S, et al. Dihydroartemisinin alleviates morphine-induced neuroinflammation in BV-2 cells. Bioengineered. 2021Dec;12(2):9401–9410. PMID: 34854364.
  • Jie Y, Ye L, Chen H, et al. ELFN1-AS1 accelerates cell proliferation, invasion and migration via regulating miR-497-3p/CLDN4 axis in ovarian cancer. Bioengineered. 2020Dec;11(1):872–882. PMID: 32779991; PMCID: PMC8291874.
  • Den Hoed CM, Kuipers EJ. Gastric Cancer: how Can We Reduce the Incidence of this Disease? Curr Gastroenterol Rep. 2016Jul;18(7):34. PMID: 27184043; PMCID: PMC4868864.
  • Chia NY, Tan P. Molecular classification of gastric cancer. Ann Oncol. 2016May;27(5):763–769. Epub 2016 Feb 9. PMID: 26861606.
  • Vega-Benedetti AF, Loi E, Moi L, et al. Clustered protocadherins methylation alterations in cancer. Clin Epigenetics. 2019Jul9;11(1):100. PMID: 31288858; PMCID: PMC6617643.
  • Ma B, Li Y, Ren Y. Identification of a 6-lncRNA prognostic signature based on microarray re-annotation in gastric cancer. Cancer Med. 2020Jan;9(1):335–349. Epub 2019 Nov 19. PMID: 31743579; PMCID: PMC6943089.
  • Wei GH, Wang X. lncRNA MEG3 inhibit proliferation and metastasis of gastric cancer via p53 signaling pathway. Eur Rev Med Pharmacol Sci. 2017 Oct;21(17):3850–3856. PMID: 28975980.
  • Zhao J, Du P, Cui P, et al. LncRNA PVT1 promotes angiogenesis via activating the STAT3/VEGFA axis in gastric cancer. Oncogene. 2018Jul;37(30):4094–4109. Epub 2018 Apr 30. PMID: 29706652.
  • Yu Y, Zhang W, Li A, et al. Association of Long Noncoding RNA Biomarkers With Clinical Immune Subtype and Prediction of Immunotherapy Response in Patients With Cancer. JAMA Network Open. 2020Apr1;3(4):e202149. PMID: 32259264; PMCID: PMC7139278.
  • Xu C, Liu M, Jia D, et al. lncRNA TINCR SNPs and Expression Levels Are Associated with Bladder Cancer Susceptibility. Genet Test Mol Biomarkers. 2021Jan;25(1):31–41. Epub 2020 Dec 28. PMID: 33372851.
  • Li XL, Subramanian M, Jones MF, et al. Long Noncoding RNA PURPL Suppresses Basal p53 Levels and Promotes Tumorigenicity in Colorectal Cancer. Cell Rep. 2017Sep5;20(10):2408–2423. PMID: 28877474; PMCID: PMC5777516.
  • Moridi H, Karimi J, Tavilani H, et al. Overexpression of PURPL and downregulation of NONHSAT062994 as potential biomarkers in gastric cancer. Life Sci. 2019Nov15;237:116904. Epub 2019 Oct 10. PMID: 31606380.
  • Xu F, Ji Z, He L, et al. Downregulation of LINC01021 by curcumin analog Da0324 inhibits gastric cancer progression through activation of P53. Am J Transl Res. 2020 Jul 15;12(7):3429–3444. PMID: 32774710; PMCID: PMC7407729.
  • Hao NB, He YF, Li XQ, et al. The role of miRNA and lncRNA in gastric cancer. Oncotarget. 2017Jul12;8(46):81572–81582. PMID: 29113415; PMCID: PMC5655310.
  • Mahmoudi E, Cairns MJ. MiR-137: an important player in neural development and neoplastic transformation. Mol Psychiatry. 2017Jan;22(1):44–55. Epub 2016 Sep 13. PMID: 27620842; PMCID: PMC5414082.
  • Du Y, Chen Y, Wang F, et al. miR-137 plays tumor suppressor roles in gastric cancer cell lines by targeting KLF12 and MYO1C. Tumour Biol. 2016Oct;37(10):13557–13569. Epub 2016 Jul 28. PMID: 27468717.
  • Li W, Duan J, Shi W, et al. Long Non-Coding RNA NCK1-AS1 Serves an Oncogenic Role in Gastric Cancer by Regulating miR-137/NUP43 Axis. Onco Targets Ther. 2020Oct6;13:9929–9939. PMID: 33116577; PMCID: PMC7547806.
  • Zhijun Z, Jingkang H. MicroRNA-520e suppresses non-small-cell lung cancer cell growth by targeting the Zbtb7a-mediated Wnt signaling pathway. Biochem Biophys Res Commun. 2017Apr22;486(1):49–56. Epub 2017 Feb 27. PMID: 28242196.
  • Mao A, Chen M, Qin Q, et al. ZBTB7A promotes migration, invasion, and metastasis of human breast cancer cells through NF-κB-induced epithelial-mesenchymal transition in vitro and in vivo. J Biochem. 2019Dec1;166(6):485–493. PMID: 31385585.
  • Wang L, Zhang MX, Zhang MF, et al. ZBTB7A functioned as an oncogene in colorectal cancer. BMC Gastroenterol. 2020Nov9;20(1):370. PMID: 33167891; PMCID: PMC7650168.
  • Shi DB, Wang YW, Xing AY, et al. C/EBPα-induced miR-100 expression suppresses tumor metastasis and growth by targeting ZBTB7A in gastric cancer. Cancer Lett. 2015Dec28;369(2):376–385. Epub 2015 Sep 25. PMID: 26404754.
  • Sun G, Peng B, Xie Q, et al. Upregulation of ZBTB7A exhibits a tumor-suppressive role in gastric cancer cells. Mol Med Rep. 2018Feb;17(2):2635–2641. Epub 2017 Nov 20. PMID: 29207095.
  • Chen H, Zhou L, Wu X, et al. The PI3K/AKT pathway in the pathogenesis of prostate cancer. Front Biosci (Landmark Ed). 2016Jun1;21(5):1084–1091. PMID: 27100493.
  • Ma Y, Zhou G, Li M, et al. Long noncoding RNA DANCR mediates cisplatin resistance in glioma cells via activating AXL/PI3K/AKT/NF-κB signaling pathway. Neurochem Int. 2018Sep; 118: 233–241. Epub 2018 Mar 21. PMID: 29572052.
  • Sha M, Ye J, Zhang LX, et al. Celastrol induces apoptosis of gastric cancer cells by miR-21 inhibiting PI3K/Akt-NF-κB signaling pathway. Pharmacology. 2014;93(1–2):39–46. Epub 2014 Jan 15. PMID: 24434352.